Capstone Investment Advisors, LLC Bristol Myers Squibb CO Put Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $226,061 - $294,975	5,700 Added 1.15%	500,000 $25.9 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $13.5 Million - $17.7 Million	334,800 Added 209.91%	494,300 $20.5 Million
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $10.7 Million - $12.1 Million	-222,600 Reduced 58.26%	159,500 $8.65 Million
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $6.06 Million - $7.24 Million	125,100 Added 48.68%	382,100 $19.6 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $2.44 Million - $2.73 Million	42,200 Added 19.65%	257,000 $14.9 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $1.26 Million - $1.39 Million	19,700 Added 10.1%	214,800 $13.7 Million
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $4.85 Million - $5.5 Million	-73,800 Reduced 27.45%	195,100 $13.5 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $5.41 Million - $6.41 Million	79,000 Added 41.6%	268,900 $19.3 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $9,646 - $5.7 Million	-74,200 Reduced 28.1%	189,900 $13.5 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $51.3 Million - $56.5 Million	-706,900 Reduced 72.8%	264,100 $20.3 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $41.4 Million - $49.6 Million	-673,000 Reduced 40.94%	971,000 $70.9 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $21.1 Million - $24.6 Million	394,200 Added 31.54%	1,644,000 $103 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $16.3 Million - $19.1 Million	-275,600 Reduced 18.07%	1,249,800 $74 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $34 Million - $37 Million	549,300 Added 56.27%	1,525,400 $102 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $7.93 Million - $8.92 Million	133,600 Added 15.86%	976,100 $61.6 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $6.48 Million - $7.34 Million	112,200 Added 15.36%	842,500 $52.3 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $7.31 Million - $8.1 Million	127,200 Added 21.09%	730,300 $44 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $25.2 Million - $29.5 Million	459,800 Added 320.87%	603,100 $35.5 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $45.6 Million - $66.2 Million	-982,000 Reduced 87.27%	143,300 $7.99 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $29.8 Million - $38.9 Million	606,500 Added 116.9%	1,125,300 $72.2 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $6.13 Million - $7.27 Million	143,300 Added 38.16%	518,800 $26.3 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $1.5 Million - $1.66 Million	33,700 Added 9.86%	375,500 $17 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $5.06 Million - $6.04 Million	112,200 Added 48.87%	341,800 $16.3 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $3.72 Million - $4.82 Million	76,300 Added 49.77%	229,600 $11.9 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $6.4 Million - $7.22 Million	116,000 Added 310.99%	153,300 $9.52 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $1.62 Million - $2.02 Million	32,000 Added 603.77%	37,300 $2.06 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $317,576 - $365,594	5,300 New	5,300 $335,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.16 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.37 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.53 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account